Cefepime therapy for monomicrobial Enterobacter cloacae bacteremia: unfavorable outcomes in patients infected by cefepime-susceptible dose-dependent isolates
ABSTRACT A new category of cefepime susceptibility, susceptible dose dependent (SDD),
for Enterobacteriaceae, has been suggested to maximize its clinical use. However, clinical
evidence supporting such a therapeutic strategy is limited. A retrospective study of 305
adults with monomicrobial Enterobacter cloacae bacteremia at a medical center from 2008
to 2012 was conducted. The patients definitively treated with in vitro active cefepime (cases)
were compared with those treated with a carbapenem (controls) to assess therapeutic …
for Enterobacteriaceae, has been suggested to maximize its clinical use. However, clinical
evidence supporting such a therapeutic strategy is limited. A retrospective study of 305
adults with monomicrobial Enterobacter cloacae bacteremia at a medical center from 2008
to 2012 was conducted. The patients definitively treated with in vitro active cefepime (cases)
were compared with those treated with a carbapenem (controls) to assess therapeutic …
Cefepime therapy for monomicrobial Enterobacter cloacae bacteremia: unfavorable outcomes in patients infected by cefepime-susceptible dose-dependent isolates.
LNY Lee NanYao, LCC Lee ChingChi… - 2015 - cabidigitallibrary.org
A new category of cefepime susceptibility, susceptible dose dependent (SDD), for
Enterobacteriaceae, has been suggested to maximize its clinical use. However, clinical
evidence supporting such a therapeutic strategy is limited. A retrospective study of 305
adults with monomicrobial Enterobacter cloacae bacteremia at a medical center from 2008
to 2012 was conducted. The patients definitively treated with in vitro active cefepime (cases)
were compared with those treated with a carbapenem (controls) to assess therapeutic …
Enterobacteriaceae, has been suggested to maximize its clinical use. However, clinical
evidence supporting such a therapeutic strategy is limited. A retrospective study of 305
adults with monomicrobial Enterobacter cloacae bacteremia at a medical center from 2008
to 2012 was conducted. The patients definitively treated with in vitro active cefepime (cases)
were compared with those treated with a carbapenem (controls) to assess therapeutic …
以上显示的是最相近的搜索结果。 查看全部搜索结果